Chemo-Preventative Agents Will Move To New Cancer Office In Fall
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Office of Oncology Drug Products will assume responsibility for all chemo-preventative drug reviews beginning in the fall, Office of New Drugs Director John Jenkins, MD, told reporters July 16